Jess Roper

Chief Financial Officer, Dexcom.

Companies

REVELATION BIOSCIENCES, INC.Board member Jan 20, 2022 to now¹
BIOLASE, INCBoard member Jun 19, 2018 to Jun 12, 2023²
DexcomChief financial officer Aug 6, 2007 to Apr 20, 2017³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

REVELATION BIOSCIENCES, INC. REVB44,839 shares⁴$34.1K at $0.76Aug 17, 2026
BIOLASE, INC0 shares⁵Apr 28, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Aug 17, 2026Granted 32,011 shares of REVELATION BIOSCIENCES, INC.⁴
Feb 3, 2026Shares withheld for tax 1,591 shares at $1.85 of REVELATION BIOSCIENCES, INC.⁶
Jan 8, 2026Granted 41,981 shares at $0.90 of REVELATION BIOSCIENCES, INC.⁷
Oct 29, 2025Granted 15,625 shares at $1.28 of REVELATION BIOSCIENCES, INC.⁸
Feb 11, 2025Granted 181 shares at $3.87 of REVELATION BIOSCIENCES, INC.⁹
Apr 28, 2022Returned to company 346 shares of BIOLASE, INC⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARREVELATION BIOSCIENCES, INC., Board member
2
SEC EDGARBIOLASE, INC, Board member
3
SEC EDGARDexcom, Chief financial officer
4
SEC EDGARREVELATION BIOSCIENCES, INC. shares after the filing of Aug 17, 2026
5
SEC EDGARBIOLASE, INC shares after the filing of Apr 28, 2022
6
SEC EDGARForm 4 filed Feb 5, 2026
7
SEC EDGARForm 4 filed Jan 12, 2026
8
SEC EDGARForm 4 filed Oct 31, 2025
9
SEC EDGARForm 4 filed Feb 13, 2025